Exact Sciences Announces Fourth Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Exact Sciences (EXAS) Misses Q4 EPS by 24c, Revenue Beats, Offers Guidance
February 22, 2022 4:11 PM ESTExact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($1.28), $0.24 worse than the analyst estimate of ($1.04). Revenue for the quarter came in at $473.8 million versus the consensus estimate of $449 million.
GUIDANCE:
Exact Sciences sees FY2022 revenue of $1.975-2.027 billion, versus the consensus of $1.99... More
